In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $1.27 in the prior trading day, Geron Corp (NASDAQ: GERN) closed at $1.24, down -2.36%. In other words, the price has decreased by -$2.36 from its previous closing price. On the day, 9.28 million shares were traded. GERN stock price reached its highest trading level at $1.28 during the session, while it also had its lowest trading level at $1.21.
Ratios:
Our goal is to gain a better understanding of GERN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.79 and its Current Ratio is at 7.87. In the meantime, Its Debt-to-Equity ratio is 0.96 whereas as Long-Term Debt/Eq ratio is at 0.89.
On May 08, 2025, Scotiabank Downgraded its rating to Sector Perform which previously was Sector Outperform but kept the price unchanged to $1.50.
B. Riley Securities Downgraded its Buy to Neutral on February 27, 2025, whereas the target price for the stock was revised from $3.50 to $2.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 09 ’25 when LAWLIS V BRYAN bought 13,300 shares for $1.18 per share. The transaction valued at 15,667 led to the insider holds 13,300 shares of the business.
Samuels Scott Alan bought 15,000 shares of GERN for $24,150 on Feb 27 ’25. The EVP, Chief Legal Officer now owns 26,682 shares after completing the transaction at $1.61 per share. On Feb 27 ’25, another insider, SCARLETT JOHN A, who serves as the Chairman, President and CEO of the company, bought 12,500 shares for $1.76 each. As a result, the insider paid 22,062 and bolstered with 12,500 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GERN now has a Market Capitalization of 807027584 and an Enterprise Value of 525003168. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.81 while its Price-to-Book (P/B) ratio in mrq is 3.05. Its current Enterprise Value per Revenue stands at 3.193 whereas that against EBITDA is -6.819.
Stock Price History:
The Beta on a monthly basis for GERN is 0.59, which has changed by -0.7026379 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, GERN has reached a high of $4.50, while it has fallen to a 52-week low of $1.09. The 50-Day Moving Average of the stock is -8.43%, while the 200-Day Moving Average is calculated to be -28.35%.
Shares Statistics:
The stock has traded on average 8.47M shares per day over the past 3-months and 8071470 shares per day over the last 10 days, according to various share statistics. A total of 637.85M shares are outstanding, with a floating share count of 604.36M. Insiders hold about 5.28% of the company’s shares, while institutions hold 76.75% stake in the company. Shares short for GERN as of 1759190400 were 89775024 with a Short Ratio of 10.60, compared to 1756425600 on 88536749. Therefore, it implies a Short% of Shares Outstanding of 89775024 and a Short% of Float of 14.71.
Earnings Estimates
A detailed examination of Geron Corp (GERN) is currently in progress, with 3.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.02 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.09 and -$0.15 for the fiscal current year, implying an average EPS of -$0.12. EPS for the following year is -$0.03, with 4.0 analysts recommending between $0.03 and -$0.09.
Revenue Estimates
8 analysts predict $54.44M in revenue for . The current quarter. It ranges from a high estimate of $58.9M to a low estimate of $49M. As of . The current estimate, Geron Corp’s year-ago sales were $28.27MFor the next quarter, 8 analysts are estimating revenue of $61.45M. There is a high estimate of $70.8M for the next quarter, whereas the lowest estimate is $53.7M.
A total of 8 analysts have provided revenue estimates for GERN’s current fiscal year. The highest revenue estimate was $218.3M, while the lowest revenue estimate was $191.4M, resulting in an average revenue estimate of $204.72M. In the same quarter a year ago, actual revenue was $76.99MBased on 8 analysts’ estimates, the company’s revenue will be $321.97M in the next fiscal year. The high estimate is $413.2M and the low estimate is $266.39M.
